Compare DOCN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOCN | ICUI |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.9B |
| IPO Year | 2021 | 1995 |
| Metric | DOCN | ICUI |
|---|---|---|
| Price | $67.89 | $126.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | $65.38 | ★ $182.25 |
| AVG Volume (30 Days) | ★ 3.0M | 266.1K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.15 | 100.62 |
| EPS | ★ 2.52 | 0.03 |
| Revenue | $901,427,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $30.02 | $4.46 |
| P/E Ratio | ★ $26.31 | $4,287.33 |
| Revenue Growth | ★ 15.48 | N/A |
| 52 Week Low | $25.45 | $107.02 |
| 52 Week High | $70.43 | $160.29 |
| Indicator | DOCN | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 29.24 |
| Support Level | $45.51 | $121.49 |
| Resistance Level | $70.43 | $136.39 |
| Average True Range (ATR) | 4.62 | 5.54 |
| MACD | 0.90 | -2.01 |
| Stochastic Oscillator | 88.57 | 8.59 |
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.